NIH-funded research R15 grant

Exploring how a cannabinoid receptor can reduce inflammation in the breast during breastfeeding.

Official title: Investigating the therapeutic potential of CB2 in modulation of inflammation in the mammary gland during lactation

Funded at University of Puerto Rico at Aguadilla · NIH-10514546 · Data updated 2026-11-12

This study is looking at how a specific receptor in the body might help reduce inflammation caused by mastitis, a painful condition some women experience while breastfeeding, to find ways to make breastfeeding easier and more comfortable.

More Lactation research and trials

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionUniversity of Puerto Rico at Aguadilla
NIH-funded
Lab location1 site (Aguadilla, United States)
Project startSeptember 1, 2022
Project endJuly 31, 2025
Funding year2022
Award (this year)$282,665
NIH project number1R15HD109919-01
Project IDNIH-10514546 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are postpartum women experiencing symptoms of mastitis or inflammation in the breast.

Less likely to help

Patients who are not postpartum or do not experience mastitis may not benefit from this research.

What this research studies

This research investigates the role of the cannabinoid type 2 (CB2) receptor in reducing inflammation associated with mastitis, a condition that can occur in women during the early weeks of breastfeeding. The study aims to understand how activating this receptor can decrease harmful inflammatory cytokines and reactive oxygen species that damage mammary tissue and affect milk production. By utilizing various agonists that activate CB2, the research seeks to identify potential therapeutic strategies to alleviate inflammation and support breastfeeding.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that help women maintain breastfeeding by reducing inflammation and associated complications.

How similar studies have gone: Previous studies have shown promising results regarding the anti-inflammatory effects of CB2 activation in chronic inflammatory conditions, suggesting potential for success in this area.

Where this research is happening

  • University of Puerto Rico at Aguadilla
    Aguadilla, United States
    Active

Researchers

  • Principal investigator: Perez Laspiur, Juliana — University of Puerto Rico at Aguadilla
  • Study coordinator: Perez Laspiur, Juliana

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.